GLABF (Gemina Laboratories) Stock Based Compensation: $0.20 Mil (TTM As of Oct. 2025)


What is Gemina Laboratories Stock Based Compensation?

Gemina Laboratories GLABF -27.59% Stock Based Compensation is $0.20 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's Stock Based Compensation for the three months ended in Oct. 2025 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Oct. 2025 was $0.20 Mil.

Gemina Laboratories Stock Based Compensation Related Terms

Gemina Laboratories Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Stock Based Compensation Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Stock Based Compensation
0.00 0.56 0.29 0.42 0.36

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.19 0.01 0.00 0.00

Gemina Laboratories Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.20 Mil.

What does a Stock Based Compensation of $0.20 Mil mean?
Gemina Laboratories (GLABF) has a Stock Based Compensation of $0.20 Mil as of Oct. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Gemina Laboratories and its competitors.
Is Gemina Laboratories' Stock Based Compensation too high?
Gemina Laboratories' current Stock Based Compensation is $0.20 Mil.
How does Gemina Laboratories' Stock Based Compensation compare to VRTX and REGN?
Gemina Laboratories' Stock Based Compensation of $0.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Gemina Laboratories and its competitors. Gemina Laboratories's current Stock Based Compensation is $0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Stock Based Compensation of $0.20 Mil. The current Stock Based Compensation is $0.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Stock Based Compensation is $0.20 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.